Celularity Stock (NASDAQ: CELU) stock price, news, charts, stock research, profile.
Open | $2.950 |
Close | - |
Volume / Avg. | 16.508K / 68.244K |
Day Range | 2.950 - 3.300 |
52 Wk Range | 1.590 - 8.900 |
Market Cap | $65.457M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 5.42% |
Days to Cover | 17.43 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Celularity (NASDAQ: CELU) through any online brokerage.
Other companies in Celularity’s space includes: Intensity Therapeutics (NASDAQ:INTS), Curis (NASDAQ:CRIS), CollPlant Biotechnologies (NASDAQ:CLGN), vTv Therapeutics (NASDAQ:VTVT) and AEON Biopharma (AMEX:AEON).
The latest price target for Celularity (NASDAQ: CELU) was reported by Morgan Stanley on Monday, January 30, 2023. The analyst firm set a price target for 1.00 expecting CELU to fall to within 12 months (a possible -66.72% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Celularity (NASDAQ: CELU) is $3.005 last updated Today at May 30, 2024 at 3:17 PM EDT.
There are no upcoming dividends for Celularity.
Celularity’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Celularity.
Celularity is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.